ClinicalTrials.Veeva

Menu

Exercise Training in Grown-up Congenital Heart Disease (ExTra-GUCH)

A

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Status

Unknown

Conditions

Congenital Heart Disease

Treatments

Behavioral: exercise training

Study type

Interventional

Funder types

Other

Identifiers

NCT02825472
NL5378201815

Details and patient eligibility

About

Rationale: Regular physical activity and aerobic exercise training are related to decreased cardiovascular mortality in healthy individuals, as well as in individuals with cardiovascular risk factors and cardiac patients. Unfortunately, no such data is available on exercise training in adult patients with congenital heart disease.

Objective: The objective of the ExTra GUCH trial is to assess whether encouragement of a six-month sports participation program in addition to usual care in symptomatic adult patients with congenital heart disease improves exercise capacity and quality of life, and lowers serum N-terminal prohormone brain natriuretic peptide (NT-proBNP) levels.

Study design: International, multi-centre parallel randomized controlled trial.

Study population: Adult patients with congenital heart disease, who are in New York Heart Association (NYHA) class II or III.

Intervention (if applicable): The intervention group receives a six-month individualized exercise training program, the control group receives usual care.

Main study parameters/endpoints: The primary outcome is the change in peakVO2 between patients in the sports participation group, and the control group. Secondary outcome measures are change in NYHA functional class, quality of life, and NT-proBNP levels. The primary safety outcome is the composite of all hospitalizations, and all deaths during, or within three hours after exercise. The secondary safety outcome is the composite of all exercise related injuries for which medical attention is sought.

Full description

The investigators intend to submit the trial design of this study for this purpose.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years
  • Congenital heart disease of all complexities
  • NYHA Class II or III

Exclusion criteria

  • Inability to give informed consent
  • Inability to participate in an exercise training program
  • Exercise-induced arrhythmia and/or ischemia
  • Cyanosis at rest
  • Pregnancy
  • Major cardiovascular event and/or procedure within three months previous to inclusion.
  • Participation in interventional clinical trial

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Exercise training program
Active Comparator group
Description:
Six-months sports participation, three times per week for 30 minutes in the target heart rate zone
Treatment:
Behavioral: exercise training
No exercise training program
No Intervention group
Description:
no exercise training program, usual care

Trial contacts and locations

2

Loading...

Central trial contact

Michiel Winter, MD, PhD; Berto Bouma, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems